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Topoisomerase II (TOP II) is an enzyme that alters the topological state of the DNA 
double helix during physiological processes through the formation of transient DNA 
double strand breaks. Two TOP II isoforms are known: TOP IIα is essential for proper 
separation of chromosomes in mitotic cells, whereas TOP IIβ is primarily associated with 
gene transcription. Anthracycline antibiotics (ANT) belong to the group of topoisomerase 
poisons that stabilize the covalent complex of TOP II and DNA. This prevents 
the religation of the DNA double strand breaks and thus causes irreversible DNA damage 
leading to programmed cell death. Although ANTs are frequently administered in various 
antineoplastic protocols (hematooncological malignancies, hormone-dependent tumors 
and others), the therapy still possess a high risk of irreversible cardiotoxicity. 
The mechanism of cardiotoxicity remains unraveled. However, it has been previously 
discussed that TOP IIβ inhibition could play a key role in this process. 
The practical aim of this work was to optimize methodology of RNA interference using 
siRNA molecules targeting the TOP IIβ isoform in human tumor suspension cell line 
HL-60. The transfection was performed by the electroporation. Evaluation of TOP IIβ 
was accomplished both on mRNA level by RT-qPCR and protein level via 
immunoblotting. Furthermore, antiproliferative effect of the Daunorubicin as a model 
ANT drug was investigated in TOP IIβ depleted cells. 
